PrimeC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PrimeC, covering 2025-09-05 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease. [Phase 2]